FF 705

Known as: FF-705 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-1992
012319821992

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
alpha-Difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase, reduced intestinal lesions in tumor-bearing mice… (More)
Is this relevant?
1988
1988
5-FU is metabolized to FUTP and FdUMP in tumor cells and exhibits RNA- and DNA-directed cytotoxicity. Biochemical modulation of… (More)
Is this relevant?
1984
1984
  • Gan to kagaku ryoho. Cancer & chemotherapy
  • 1984
Clinical efficacy of new fluorouridine derivative, FF-705, was studied in 108 patients with advanced malignant tumors. Partial… (More)
Is this relevant?
1984
1984
  • Gan to kagaku ryoho. Cancer & chemotherapy
  • 1984
A phase I study of a new floxuridine derivative, FF-705, was performed in patients with various types of solid tumors. Efficacy… (More)
Is this relevant?
1984
1984
Many derivatives modifying chemical structures have been synthesized from several drugs. These include following antibiotics… (More)
Is this relevant?
1982
1982
5-FU analogs being investigated in Japan are; 5-FU, FT, FD-1, HCFU, UFT, TAC-278, 5'-DFUR, FF-705, and TK-117. They exert… (More)
Is this relevant?